Android/BankBot-YNRK is currently targeting users in Indonesia by masquerading as legitimate applications.
Day after resigning, Tidmarsh now says he’ll fight exit from FDA
One day after stepping down as CDER Director, George Tidmarsh has said he will fight the investigations into his conduct and is reconsidering his decision. Tidmarsh’s intentions were shared with a handful of senior FDA …
AbbVie gets early win in Oklahoma 340B fight, but faces setback in Colorado
Two federal district courts have reached opposite conclusions in cases challenging states’ authority to regulate how drugmakers distribute 340B discounts. An Oklahoma federal judge on Friday preliminarily blocked the state from forcing AbbVie, Novartis and …
uniQure poleaxed as FDA blocks Huntington’s therapy
uniQure has revealed that the FDA has said it is not prepared to review its Huntington’s gene therapy in what seems to be a change in policy.
Hackers Weaponize Remote Tools to Hijack Cargo Freight
Researchers uncovered a new threat campaign in which attackers use RMM tools to steal physical cargo out of the supply chain.
Lilly earmarks $3B for new European obesity pill factory
Eli Lilly plans to build another facility to make its oral GLP-1 drug orforglipron. The $3 billion site will be located in Katwijk, the Netherlands. In addition to orforglipron, the new site will make other …
UK regulators look to speed up how rare disease therapies reach the market
The UK’s medicines regulatory agency said it is working to “overhaul” its framework for approving rare disease therapies. The Medicines and Healthcare products Regulatory Agency (MHRA) said on Sunday it is …
Pfizer files another lawsuit against Metsera, Novo Nordisk
Metsera says Novo Nordisk’s takeover offer is superior to one filed by Pfizer, and the latter files a new lawsuit to try to force their deal through.
Metsera calls Pfizer threats ‘nonsense’ as rift widens between companies
Pfizer and Novo Nordisk’s battle over obesity biotech Metsera is getting ugly. On Monday, Metsera asked the Delaware Court of Chancery to deny Pfizer’s request for a hearing to determine whether to temporarily block Metsera …
TScan to cut a third of its staff; Iovance advances Amtagvi in lung cancer
Plus, news about Krystal Biotech, Serina Therapeutics, Rein Therapeutics, Knight Therapeutics, Kyverna Therapeutics, Roche, Alvotech, Savara and MindMed: 💼 TScan Therapeutics to lay off 66 workers: The biotech said it reached …